Patent US5869602A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5869602A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptide derivatives

Assignee: Novo Nordisk AS
•
Filing: 1995-05-23
•
Granted: 1999-02-09
•
Expires: 2015-05-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a pharmacologically active peptide hormone derivative in which the parent peptide hormone has been modified by introducing either a lipophilic substituent, W, in the N-terminal amino acid or a lipophilic substituent, Z, in the C-terminal amino acid of the parent peptide hormone or an analogue thereof, said lipophilic substituent having from 8 to 40 carbon atoms, has a protracted profile of action.

Inventors

  • 👤 Ib Jonassen
  • 👤 Svend Havelund
  • 👤 Per Hertz Hansen
  • 👤 Peter Kurtzhals
  • 👤 John Halstr.o slashed.m

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:12
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/26; A61K38/2242; A61K38/31; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61P; A61P25/00; A61P25/04; A61P3/00; A61P3/08; A61P3/10; A61P3/12; A61P3/14; A61P31/00; A61P31/12; A61P39/00; A61P39/06; A61P5/00; A61P5/02; A61P5/10; A61P5/14; A61P5/18; A61P5/22; A61P5/38; A61P5/48; A61P5/50; A61P7/00; A61P7/06; A61P9/00; A61P9/12; C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/665; A61K38/04; A61K38/08; A61K38/095

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 73 words
A peptide derivative which is: Lys 30 (N.sup.ε -lipophilic substituent) glucagon, wherein the lipophilic substituent has 8 to 40 carbon atoms and (a) is a straight chain fatty acid or (b) consists of a spacer selected from the group consisting of Glu and Asp, wherein said spacer forms one amide bond with the ε-amino group of Lys 30 and a further amide bond with the carboxyl group of a straight chain fatty acid.
Claim 2
Dependent Claim 73 words
A peptide derivative which is: Lys 30 (N.sup.ε -lipophilic substituent) glucagon, wherein the lipophilic substituent has 8 to 40 carbon atoms and (a) is a straight chain fatty acid or (b) consists of a spacer selected from the group consisting of Glu and Asp, wherein said spacer forms one amide bond with the ε-amino group of Lys 30 and a further amide bond with the carboxyl group of a straight chain fatty acid.
Claim 3
Dependent Claim 12 words
The peptide derivative of claim 1, wherein the lipophilic substituent is tetradecanoyl.
Claim 4
Dependent Claim 12 words
The peptide derivative of claim 2, wherein the lipophilic substituent is decanoyl.

References Cited (Backward Citations)

US4430326A Cited
US5135736A Cited
WO1993021320A1 Cited
EP0511600A2 Cited
WO1993015750A1 Cited
US5359030A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-02-08 2002-08-10 2003-02-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-02-08 2006-08-10 2007-02-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-02-08 2010-08-10 2011-02-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag